These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23190096)
1. Critical role for drug delivery in the development of new ophthalmic treatments. Sheardown H Future Med Chem; 2012 Nov; 4(17):2123-5. PubMed ID: 23190096 [No Abstract] [Full Text] [Related]
2. Are contact lenses the solution for effective ophthalmic drug delivery? Bengani L; Chauhan A Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101 [No Abstract] [Full Text] [Related]
3. Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Jung HJ; Chauhan A Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750 [TBL] [Abstract][Full Text] [Related]
10. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Del Amo EM; Urtti A Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911 [TBL] [Abstract][Full Text] [Related]
11. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Myles ME; Neumann DM; Hill JM Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884 [TBL] [Abstract][Full Text] [Related]
12. Ocular drug delivery-eye on innovation. Rupenthal ID; O'Rourke M Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597 [No Abstract] [Full Text] [Related]
13. Iontophoresis: a non-invasive ocular drug delivery. Eljarrat-Binstock E; Domb AJ J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678 [TBL] [Abstract][Full Text] [Related]
14. Controlled release of betamethasone from vitamin E-loaded silicone-based soft contact lenses. Rad MS; Sajadi Tabassi SA; Moghadam MH; Mohajeri SA Pharm Dev Technol; 2016 Nov; 21(7):894-899. PubMed ID: 26334597 [TBL] [Abstract][Full Text] [Related]
15. Drug delivery systems for the eye. Kearns VR; Williams RL Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285 [TBL] [Abstract][Full Text] [Related]
16. Diffusion-Based Design of Multi-Layered Ophthalmic Lenses for Controlled Drug Release. Pimenta AF; Serro AP; Paradiso P; Saramago B; Colaço R PLoS One; 2016; 11(12):e0167728. PubMed ID: 27936138 [TBL] [Abstract][Full Text] [Related]
17. [Progress in sustained-release drug delivery system for treatment of posterior segment eye diseases]. Sun SM; Cheng LY Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):847-50. PubMed ID: 24330936 [TBL] [Abstract][Full Text] [Related]
18. [Biological availability of ophthalmic preparations. 2. Ophthalmic therapeutic systems]. Masteiková R; Chalupová Z; Savickas A Ceska Slov Farm; 2004 Sep; 53(5):211-8. PubMed ID: 15506702 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery. Xu J; Li X; Sun F Drug Deliv; 2011 Feb; 18(2):150-8. PubMed ID: 21043996 [TBL] [Abstract][Full Text] [Related]
20. Interview with Paul Ashton: sustained-release drug delivery to the eye. Ashton P Ther Deliv; 2013 Mar; 4(3):297-9. PubMed ID: 23442076 [No Abstract] [Full Text] [Related] [Next] [New Search]